Full history for every metric is available with a Kvantra account

Stock profile

Can B Corp. (CANB)

Country: United States of AmericaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: OTC

Delisted · last close 21 Oct 2025

Current price
0.02 USD-3.90%
Last close 21 Oct 2025
Benchmarks

Key financial summary

Financials in USD
201920202021202220232024TTM
Total revenue$m2257201
Operating profit$m-5-11
Net profit$m-5-9-12-15-10-10-13
EPS reported$-0.17-0.30
Operating cashflow per share$-0.00-0.00
Capex per share$0.000.00
FCF per share$-0.00-0.00
Free cash flow$m-00
Net debt$m89
Book value equity$m-13-10
Book value per share$-0.22-0.15
Number of sharesm58.3765.44
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201920202021202220232024TTM
Value
P/E TTMx--
P/B LTMx-0.16-0.15
P/S LTMx0.001.52
P/FCF LTMx-9.396.06
EV/EBITDA LTMx-1.36-1.07
EV/Sales LTMx0.0010.70
Earnings Yield LTM%-490.35%-911.89%
FCF Yield%-10.65%16.50%
Quality
ROE%80.19%148.68%
ROIC%107.66%107.66%
Operating margin%0.00%0.00%
Gross margin%0.00%0.00%
FCF/Sales%--
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%-100.00%-59.87%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-0.030.03
Net Debt/EBITDAx-1.08-1.08
EBIT/Net interestx-2.68-2.68
Net debt/market cap%398.76%602.37%
Net debt/Equityx-0.65-0.92
Gross debt/equityx-0.65-0.92

Company overview

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 21 Oct 2025

Can B Corp. (CANB)

CANB · OTC · Healthcare
0.02 USD-3.90%
Benchmarks
Financialsin USD
20232024TTM
About

Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.

IndustryDrug Manufacturers - Specialty & Generic
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free